Russia’s mRNA Cancer Vaccine Ready For Clinical Trials, Shows Tumour Shrinking Results | India Today

Share

Russia's mRNA Cancer Vaccine Ready For Clinical Trials, Shows Tumour Shrinking Results | India Today

Russian scientists have developed an mRNA cancer vaccine, named Enteromix, which is now ready for clinical trials. The announcement came from the Federal Medical and Biological Agency (FMBD). According to its head, Veronica Skvortsov, the vaccine has successfully passed pre-clinical trials, demonstrating both safety and high effectiveness. In experimental stages, the vaccine has shown significant results in shrinking tumours and slowing their growth. The treatment is reportedly effective for brain, skin, and rectal cancers. A key feature of the new vaccine is that it will be customized for each patient, tailored to their individual RNA. The vaccine is considered a potential medical breakthrough in the health sector. #russia #cancervaccine #mrna #indiatoday #healthnews #medicalbreakthrough #science #cancerresearch #clinicaltrials #enteromix #braincancer #skincancer #rectalcancer #healthcare #medicine #cancertreatment
Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you’ll never miss a new video.

All you need to do is PRESS THE BELL ICON next to the Subscribe button!

India Today TV is India’s leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.

Stay tuned for latest updates and in-depth analysis of news from India and around the world!

WhatsApp Channel: https://whatsapp.com/channel/0029Va2AnW3JENxxg7OuJv00

Download App: https://indiatoday.link/wHaj

Follow us: Official website: https://www.indiatoday.in/

Twitter: https://twitter.com/IndiaToday

Facebook: https://www.facebook.com/IndiaToday